Chimalakonda, A., J. Burke, L. Cheng, I. Catlett, A. Patel, J. Shen, I. Girgis, S. Banerjee, and J. Throup. “Selective Inhibition of Tyrosine Kinase 2 With Deucravacitinib (BMS-986165) Compared With Janus Kinase 1−3 Inhibitors”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s108, doi:10.25251/skin.4.supp.108.